DrugCite

Avandia and Cardiomyopathy

This page shows results related to Avandia and Cardiomyopathy from the FDA Adverse Event Reporting System (AERS).

Click here to learn about all Avandia adverse events.

Adverse Event
Safe Use Tools
Learn More
Comments

Avandia and Cardiomyopathy

Age

>60 Years
215
50-59 Years
172
40-49 Years
95
30-39 Years
16
20-29 Years
2

Gender

Male: 63%
Female: 36%
Gender Unknown: 1%

Outcome

What were the most common outcomes of those reporting Cardiomyopathy?

Hospitalization
619
Death
132
Other
63
Disability
27
Life Threatening
6

Reporter

Who most commonly reported Cardiomyopathy?

Consumer
244
Other
177
Lawyer
114
Pharmacist
89
Physician
76

Therapy

Of those reporting Cardiomyopathy, why were they taking Avandia?

Diabetes Mellitus
334
Type 2 Diabetes Mellitus
84
Drug Use For Unknown Indication
10
Type 1 Diabetes Mellitus
1

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.*

YESNOUNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?
Probability of an Adverse Event
Doubtful
Possible
Probable
Definite

*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Avandia, view the complete Avandia adverse event report.

Scientific Publications on Cardiomyopathy

Powered by Google

Comments

Share your experience with Avandia and Cardiomyopathy.